231 related articles for article (PubMed ID: 26887052)
1. XPG rs2296147 T>C polymorphism predicted clinical outcome in colorectal cancer.
Wang F; Zhang SD; Xu HM; Zhu JH; Hua RX; Xue WQ; Li XZ; Wang TM; He J; Jia WH
Oncotarget; 2016 Mar; 7(10):11724-32. PubMed ID: 26887052
[TBL] [Abstract][Full Text] [Related]
2. Association of
Wang XQ; Terry PD; Li Y; Zhang Y; Kou WJ; Wang MX
World J Gastroenterol; 2019 Sep; 25(34):5152-5161. PubMed ID: 31558863
[TBL] [Abstract][Full Text] [Related]
3. DNA repair genes XPC, XPG polymorphisms: relation to the risk of colorectal carcinoma and therapeutic outcome with Oxaliplatin-based adjuvant chemotherapy.
Liu D; Wu HZ; Zhang YN; Kang H; Sun MJ; Wang EH; Yang XL; Lian MQ; Yu ZJ; Zhao L; Olopade OI; Wei MJ
Mol Carcinog; 2012 Oct; 51 Suppl 1():E83-93. PubMed ID: 22213216
[TBL] [Abstract][Full Text] [Related]
4. An insight into clinical outcome of XPG polymorphisms in breast cancer.
Malik SS; Mubarik S; Masood N; Khadim MT
Mol Biol Rep; 2018 Dec; 45(6):2369-2375. PubMed ID: 30255276
[TBL] [Abstract][Full Text] [Related]
5. XPG polymorphisms are associated with prognosis of advanced non-small cell lung cancer treated with platinum-based doublet chemotherapy.
Zou HZ; Zhao YQ
Genet Mol Res; 2015 Jan; 14(1):500-6. PubMed ID: 25729984
[TBL] [Abstract][Full Text] [Related]
6. Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine.
Monzo M; Moreno I; Navarro A; Ibeas R; Artells R; Gel B; Martinez F; Moreno J; Hernandez R; Navarro-Vigo M
Oncology; 2007; 72(5-6):364-70. PubMed ID: 18204222
[TBL] [Abstract][Full Text] [Related]
7. Association between genetic variants in the
Hua RX; Zhuo ZJ; Zhu J; Jiang DH; Xue WQ; Zhang SD; Zhang JB; Li XZ; Zhang PF; Jia WH; Shen GP; He J
Aging (Albany NY); 2016 Dec; 8(12):3311-3320. PubMed ID: 27929383
[TBL] [Abstract][Full Text] [Related]
8. XPG is predictive gene of clinical outcome in advanced non-small-cell lung cancer with platinum drug therapy.
Zhang T; Sun J; Lv M; Zhang L; Wang X; Ren JC; Wang B
Asian Pac J Cancer Prev; 2013; 14(2):701-5. PubMed ID: 23621222
[TBL] [Abstract][Full Text] [Related]
9. Association between the polymorphisms in XPG gene and gastric cancer susceptibility in Chinese populations: A PRISMA-compliant meta-analysis.
Xia J; Sun R
Medicine (Baltimore); 2017 Oct; 96(42):e8213. PubMed ID: 29049208
[TBL] [Abstract][Full Text] [Related]
10. Association between XPG polymorphisms and stomach cancer susceptibility in a Chinese population.
Chen YZ; Guo F; Sun HW; Kong HR; Dai SJ; Huang SH; Zhu WW; Yang WJ; Zhou MT
J Cell Mol Med; 2016 May; 20(5):903-8. PubMed ID: 26820236
[TBL] [Abstract][Full Text] [Related]
11. Predictive impact of genetic polymorphisms in DNA repair genes on susceptibility and therapeutic outcomes to colorectal cancer patients.
Sun K; Gong A; Liang P
Tumour Biol; 2015 Mar; 36(3):1549-59. PubMed ID: 25355595
[TBL] [Abstract][Full Text] [Related]
12. XPG gene polymorphisms and cancer susceptibility: evidence from 47 studies.
Huang J; Liu X; Tang LL; Long JT; Zhu J; Hua RX; Li J
Oncotarget; 2017 Jun; 8(23):37263-37277. PubMed ID: 28416771
[TBL] [Abstract][Full Text] [Related]
13.
Liu ZQ; Chen GG; Sun RL; Chen C; Lu MY; Guan LF; Chi XL; Jian YQ; Zhu X; Liu RQ; Cai BY; Chen FF; Liu B
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30139812
[No Abstract] [Full Text] [Related]
14. XPG is a novel biomarker of clinical outcome in advanced non-small-cell lung cancer.
Yuli Y; Zhe S; Xia W; Siqing L; Zhenxuan W; Yu-Hua Z; Bing S; Jun-Wei C
Pak J Med Sci; 2013 May; 29(3):762-7. PubMed ID: 24353624
[TBL] [Abstract][Full Text] [Related]
15. Potentially functional variants in the core nucleotide excision repair genes predict survival in Japanese gastric cancer patients.
Li Y; Liu Z; Liu H; Wang LE; Onodera H; Suzuki A; Suzuki K; Wadhwa R; Elimova E; Sudo K; Shiozaki H; Estrella J; Lee JS; Song S; Tan D; Ajani JA; Wei Q
Carcinogenesis; 2014 Sep; 35(9):2031-8. PubMed ID: 24990617
[TBL] [Abstract][Full Text] [Related]
16.
Yuan L; Hu WM; Chen K; Shi Q; Lin A; Chen HT; Zhuo ZJ; Zeng L
Br J Biomed Sci; 2021 Jul; 78(3):135-140. PubMed ID: 33393424
[No Abstract] [Full Text] [Related]
17. Association between XPG gene polymorphisms and development of gastric cancer risk in a Chinese population.
Feng YB; Fan DQ; Yu J; Bie YK
Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323165
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in XPG could predict clinical outcome of platinum-based chemotherapy for advanced non-small cell lung cancer.
Hu W; Pan J; Zhao P; Yang G; Yang S
Tumour Biol; 2014 Jun; 35(6):5561-7. PubMed ID: 24615519
[TBL] [Abstract][Full Text] [Related]
19. Promoter polymorphisms in DNA repair gene ERCC5 and susceptibility to gastric cancer in Chinese.
Duan Z; He C; Gong Y; Li P; Xu Q; Sun LP; Wang Z; Xing C; Yuan Y
Gene; 2012 Dec; 511(2):274-9. PubMed ID: 22982416
[TBL] [Abstract][Full Text] [Related]
20. The association between XPG polymorphisms and cancer susceptibility: Evidence from observational studies.
Han C; Huang X; Hua R; Song S; Lyu L; Ta N; Zhu J; Zhang P
Medicine (Baltimore); 2017 Aug; 96(32):e7467. PubMed ID: 28796034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
